These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 18305268)

  • 21. [Role of T lymphocytes in systemic lupus erythematosus].
    Zubler RH; Miescher PA
    Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of anti-DNA idiotype antibodies in systemic lupus erythematosus.
    Mozes E; Mendlovic S
    Crit Rev Immunol; 1990; 10(4):329-45. PubMed ID: 2285460
    [No Abstract]   [Full Text] [Related]  

  • 23. Taming lupus.
    Zouali M
    Sci Am; 2005 Mar; 292(3):58-65. PubMed ID: 15859214
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of lupus therapy modulating autoantigen recognition.
    Okamoto A; Fujio K; Yamamoto K
    Lupus; 2010 Oct; 19(12):1474-81. PubMed ID: 20947560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies for T lymphocytes in systemic lupus erythematosus.
    Michlmayr G; Pathouli C; Huber C; Huber H
    Clin Exp Immunol; 1976 Apr; 24(1):18-25. PubMed ID: 1084815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
    Humbert M; Galanaud P
    Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The etiopathogenesis of systemic lupus erythematosus.
    Quimby FW; Schwartz RS
    Pathobiol Annu; 1978; 8():35-59. PubMed ID: 214738
    [No Abstract]   [Full Text] [Related]  

  • 30. Developments in the scientific understanding of lupus.
    Ardoin SP; Pisetsky DS
    Arthritis Res Ther; 2008; 10(5):218. PubMed ID: 18947369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disseminated lupus erythematosus: etiopathogenic factors].
    Dandavino R; Bach JF
    Ann Med Interne (Paris); 1977 Jan; 128(1):39-41. PubMed ID: 301002
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathogenesis of immune dysregulation in systemic lupus erythematosus. A troika.
    Alarcón-Segovia D
    J Rheumatol; 1984 Oct; 11(5):588-90. PubMed ID: 6239922
    [No Abstract]   [Full Text] [Related]  

  • 34. Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus.
    Tew GW; Rabbee N; Wolslegel K; Hsieh HJ; Monroe JG; Behrens TW; Brunetta PG; Keir ME
    Lupus; 2010 Feb; 19(2):146-57. PubMed ID: 19946034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune cell signaling and gene transcription in human lupus: the time has come.
    Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):221-4. PubMed ID: 15204085
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic lupus erythematosus--an autoimmune disease?
    Holborow EJ
    J Clin Pathol Suppl (R Coll Pathol); 1978; 12():144-9. PubMed ID: 365887
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytotoxicity of human lymphocytes induced by antibody: response in patients with systemic lupus erythematosus and effect of immunosuppressive treatment].
    Manni JA; de Bracco MM; Patrucco A
    Medicina (B Aires); 1974; 34(3):185-93. PubMed ID: 4547009
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of antilymphocytic antibodies in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(5):699-705. PubMed ID: 1087422
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of T lymphocyte subpopulations in patients with lupus erythematosus using monoclonal antibodies during immunocorrective therapy].
    Berenbeĭn BA; Kagramanov GV; Slavina EG
    Vestn Dermatol Venerol; 1987; (3):10-3. PubMed ID: 3300088
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lupus erythematosus--a model of an autoimmune disease].
    Sönnichsen N
    Dermatol Monatsschr; 1985; 171(8):481-92. PubMed ID: 3899754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.